HILDEN, Germany and GERMANTOWN, Maryland, November 13, 2017
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide. The milestone means QIAGEN has already exceeded its year-end 2017 goal of exceeding 2,000 cumulative placements. The rapid dissemination of QIAsymphony systems, as well as the increasing menu and new capabilities, are fueling double-digit growth in sales of the systems' related consumables.
Click here for the full press release
Investor Relations John Gilardi +49-2103-29-11711 e-mail: ir@QIAGEN.com Public Relations Dr. Thomas Theuringer +49-2103-29-11826 e-mail: pr@QIAGEN.com
SOURCE QIAGEN N.V.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All